Almost half of the respondents, 49.5%, believe that this change is long overdue, since most doctors view accreditation as nothing more than a bureaucratic procedure. Another 22.8% say that the current approaches to personnel policy in healthcare should be changed completely.

In January–August 2023, Russian manufacturers produced 455.8 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), up 0.9% from the same period last year, which is the first positive growth rate since January 2023. In physical terms, the production volume was 2.61 billion packages, down 5.3% from January–August 2022, or 51.4 billion minimum dosage units (MDUs), down 2.4%.